Naturally occurring antibodies directed against carbohydrate tumor antigens.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Advances in Experimental Medicine and Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4614-3461-0_3PMID 22903664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of the apoptosis induced by CD176 antibody in human leukemic cells.

  2011cited by this paper
• Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70−

  2011cited by this paper
• Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins

  2010cited by this paper
• Novel mechanism for the generation of human xeno-autoantibodies against the nonhuman sialic acid N-glycolylneuraminic acid

  2010cited by this paper
• Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15.

  2010cited by this paper
• Lipid raft connection between extrinsic and intrinsic apoptotic pathways.

  2009cited by this paper
• Natural human immunoglobulins in cancer immunotherapy.

  2009cited by this paper
• Anti-carbohydrate antibodies of normal sera: findings, surprises and challenges.

  2009cited by this paper
• Immune surveillance and immunotherapy: lessons from carbohydrate mimotopes.

  2009cited by this paper
• In silico analysis of antibody-carbohydrate interactions and its application to xenoreactive antibodies.

  2009cited by this paper
• Naturally occurring auto-antibodies in homeostasis and disease.

  2009cited by this paper
• Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies.

  2009cited by this paper
• Management of the human mucosal defensive barrier: evidence for glycan legislation

  2009cited by this paper
• Human milk oligosaccharides: prebiotics and beyond.

  2009cited by this paper
• Involvement of Raft Aggregates Enriched in Fas/CD95 Death-Inducing Signaling Complex in the Antileukemic Action of Edelfosine in Jurkat Cells

  2009cited by this paper
• Somatic hypermutation in peritoneal B1b cells.

  2009cited by this paper
• Generation of B Cell Memory to the Bacterial Polysaccharide α-1,3 Dextran1

  2009cited by this paper
• Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?

  2008cited by this paper
• Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system.

  2008cited by this paper
• The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance

  2008cited by this paper
• Mammalian glycosylation in immunity

  2008cited by this paper
• Treatment of neuroblastoma with human natural antibodies.

  2008cited by this paper
• Protein-glycan interactions in the control of innate and adaptive immune responses

  2008cited by this paper
• The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.

  2008cited by this paper
• Anti-GM1 antibodies as a model of the immune response to self-glycans.

  2008cited by this paper
• Multiple changes in sialic acid biology during human evolution

  2008cited by this paper
• Expression of CD175 (Tn), CD175s (sialosyl‐Tn) and CD176 (Thomsen‐Friedenreich antigen) on malignant human hematopoietic cells

  2008cited by this paper
• Involvement of α 1‐2‐fucosyltransferase I (FUT1) and surface‐expressed lewisy (CD174) in first endothelial cell–cell contacts during angiogenesis

  2008cited by this paper
• Tumor stress, cell death and the ensuing immune response

  2008cited by this paper
• Tumors: Too sweet to remember?

  2007cited by this paper
• The human IgM antibody SAM-6 induces tumor-specific apoptosis with oxidized low-density lipoprotein

  2007cited by this paper
• Down‐regulation of CD55 and CD46 expression by anti‐sense phosphorothioate oligonucleotides (S‐ODNs) sensitizes tumour cells to complement attack

  2007cited by this paper
• Recognition of tumor glycans by antigen-presenting cells.

  2006cited by this paper
• Profiling of glycans in serum for the discovery of potential biomarkers for ovarian cancer.

  2006cited by this paper
• Differential surface expression and possible function of 9-O- and 7-O-acetylated GD3 (CD60 b and c) during activation and apoptosis of human tonsillar B and T lymphocytes

  2006cited by this paper
• Prognostic impact of Thomsen–Friedenreich tumor antigen and disseminated tumor cells in the bone marrow of breast cancer patients

  2006cited by this paper
• Role of B-1a cells in autoimmunity.

  2006cited by this paper
• Anti-&agr;Gal-dependent complement-mediated cytotoxicity in metastatic melanoma

  2006cited by this paper
• The "early birds": natural IgM antibodies and immune surveillance.

  2005cited by this paper
• Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours

  2005cited by this paper
• Tumor Cell Resistance to Complement-Mediated Lysis

  2004cited by this paper
• Natural human polyreactive IgM induce apoptosis of lymphoid cell lines and human peripheral blood mononuclear cells.

  2004cited by this paper
• Antibodies against 9-O-acetylated sialoglycans: a potent marker to monitor clinical status in childhood acute lymphoblastic leukemia.

  2004cited by this paper
• PAM-1, a natural human IgM antibody as new tool for detection of breast and prostate precursors

  2004cited by this paper
• Polyreactivity of antibody molecules.

  2004cited by this paper
• Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

  2004cited by this paper
• Carbohydrate‐mediated cell adhesion in cancer metastasis and angiogenesis

  2004cited by this paper
• CFR-1 receptor as target for tumor-specific apoptosis induced by the natural human monoclonal antibody PAM-1.

  2004cited by this paper
• Thomsen-friedenreich disaccharide immunogenicity.

  2003cited by this paper
• Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo 1

  2003cited by this paper
• Better Survival of Helicobacter pylori Infected Patients with Early Gastric Cancer Is Related to a Higher Level of Thomsen‐Friedenreich Antigen‐Specific Antibodies

  2003cited by this paper
• Anti-GD2 monoclonal antibody immunotherapy: a promising strategy in the prevention of neuroblastoma relapse.

  2003cited by this paper
• Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.

  2003cited by this paper
• Natural mechanisms protecting against cancer.

  2003cited by this paper
• Difference in Prognostic Value Between Sialyl Lewisa and Sialyl Lewisx Antigen Levels in the Preoperative Serum of Gastric Cancer Patients

  2002cited by this paper
• Isolation and Characterization of Thomsen-Friedenreich-Specific Antibodies from Human Serum

  2002cited by this paper
• Human monoclonal IgM antibodies with apoptotic activity isolated from cancer patients

  2002cited by this paper
• Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.

  2001cited by this paper
• Targeting complement in therapy

  2001cited by this paper
• Glycans as legislators of host-microbial interactions: spanning the spectrum from symbiosis to pathogenicity.

  2001cited by this paper
• K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement

  2001cited by this paper
• Engineered Antibodies with Increased Activity to Recruit Complement

  2001cited by this paper
• O-acetyl sialic acid specific IgM in childhood acute lymphoblastic leukaemia

  2001cited by this paper
• Natural Hidden Autoantibodies React with Negatively Charged Carbohydrates and Xenoantigen Bdi

  2001cited by this paper
• The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis.

  2000cited by this paper
• Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli

  2000cited by this paper
• Evolutionary considerations in relating oligosaccharide diversity to biological function.

  1999cited by this paper
• Are natural antibodies involved in tumour defence?

  1999cited by this paper
• Immune evasion of tumor cells using membrane-bound complement regulatory proteins.

  1999cited by this paper
• Inhibition of Liver Metastases from Neuraminidase-Treated Colon 26 Cells by an Anti-Thomsen-Friedenreich-Specific Monoclonal Antibody

  1999cited by this paper
• Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions

  1999cited by this paper
• Characterization of glycosylphosphatidylinositol-linked molecule CD55/decay-accelerating factor as the receptor for antibody SC-1-induced apoptosis.

  1999cited by this paper
• Polyreactive antigen‐binding B cells are the predominant cell type in the newborn B cell repertoire

  1998cited by this paper
• A sequencing strategy for the localization of O-glycosylation sites of MUC1 tandem repeats by PSD-MALDI mass spectrometry.

  1997cited by this paper
• Mucins (MUC1 and MUC3) of Gastrointestinal and Breast Epithelia Reveal Different and Heterogeneous Tumor-associated Aberrations in Glycosylation

  1997cited by this paper
• Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy

  1997cited by this paper
• Carbohydrate vaccines that induce antibodies against cancer. 1. Rationale

  1997cited by this paper
• Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.

  1997cited by this paper
• Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans

  1996cited by this paper
• Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study

  1996cited by this paper
• Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma.

  1996cited by this paper
• Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.

  1996cited by this paper
• Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.

  1996cited by this paper
• Expression of thomsen‐friedenreich‐related antigens in primary and metastatic colorectal carcinomas. A reevaluation

  1995cited by this paper
• Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death.

  1995cited by this paper
• Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells

  1995cited by this paper
• Regulation of alpha 2,3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNA- phenotype in developing thymocytes.

  1993cited by this paper
• International variations in the incidence of neuroblastoma

  1992cited by this paper
• Possible functions of tumor-associated carbohydrate antigens.

  1991cited by this paper
• Rarity of neuroblastoma in East Africa.

  1990cited by this paper
• A natural autoantibody is encoded by germline heavy and lambda light chain variable region genes without somatic mutation.

  1989cited by this paper
• Proposed molecular basis of murine tumor cell-hepatocyte interaction.

  1983cited by this paper
• Antiglycolipid antibodies in human sera.

  1982cited by this paper

• Prediction model for the early recurrence of stage IA–IIA non-small cell lung cancer based on hematological indexes and imaging features

  2025cites this paper
• B cell clonality in cancer.

  2024cites this paper
• Prevalence of high affinity naturally occurring IgG2 antibodies against human chorionic gonadotropin and its subunits in patients with ovarian cyst.

  2022cites this paper
• Measurement of Low Avidity, Polyreactive Immunoglobulin G Antibodies with Increased Sensitivity by Using Low Ionic Strength Buffers

  2022cites this paper
• Natural Autoantibodies in Health and Disease

  2021cites this paper
• Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential

  2020cites this paper
• The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer

  2020influential citation
• Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis.

  2019cites this paper
• Tumor‐shed antigen CA125 blocks complement‐mediated killing via suppression of C1q‐antibody binding

  2018cites this paper
• IgM Natural Autoantibodies in Physiology and the Treatment of Disease.

  2018cites this paper
• The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer

  2018cites this paper
• Downregulation of miR‐199a/b‐5p is associated with GCNT2 induction upon epithelial–mesenchymal transition in colon cancer

  2017cites this paper
• Assessment of Anti-Tumor Cytotoxic Activity of Naturally Occurring Antibodies in Human Serum or Plasma.

  2017cites this paper
• Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients

  2016cites this paper
• Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors

  2016cites this paper
• Metabolic Glycoengineering with N-Acyl Side Chain Modified Mannosamines.

  2016cites this paper
• Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum

  2016cites this paper
• Metabolisches Glykoengineering mit N‐Acyl‐Seiten‐ ketten‐modifizierten Mannosaminen

  2016cites this paper
• Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults.

  2016cites this paper
• Natural and Induced Antibody Polyreactivity.

  2015cites this paper
• The Potential Role of Solvation in Antibody Recognition of the Lewis Y Antigen

  2015cites this paper
• The (1→6)-β-Glucan Moiety Represents a Cross-Reactive Epitope of Infection-Induced Malignancy Surveillance

  2014influential citation
• PEGylation of microbead surfaces reduces unspecific antibody binding in glycan-based suspension array.

  2014cites this paper
• IgE-based immunotherapy of cancer: challenges and chances

  2013cites this paper
• Malignancy Surveillance Cross-Reactive Epitope of Infection-Induced-Glucan Moiety Represents a β 6 )-→ The ( 1

  2013influential citation
• CD176 antiserum treatment leads to a therapeutic response in a murine model of leukemia.

  2013cites this paper
• Tumor-Associated Glycans and Immune Surveillance

  2013cites this paper